CBD-Intel

CBD in Indonesia

This page holds all of our coverage for Indonesia, including our regulatory and business news briefings, our full-length reports, and our numerous trackers, databases and live alerts.

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions